Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function
Cornell University · University of California, San Francisco · +12 more institutions
Abstract
Currently, the diagnosis of chronic obstructive pulmonary disease (COPD) requires a ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) of less than 0.70 as assessed by spirometry after bronchodilator use. However, many smokers who do not meet this definition have respiratory symptoms.
We conducted an observational study involving 2736 current or former smokers and controls who had never smoked and measured their respiratory symptoms using the COPD Assessment Test (CAT; scores range from 0 to 40, with higher scores indicating greater severity of symptoms). We examined whether current or former smokers who had preserved pulmonary function as assessed by spirometry (FEV1:FVC ≥0.70 and an FVC above the lower limit of the normal range after bronchodilator use) and had symptoms (CAT score, ≥10) had a higher risk of respiratory exacerbations than current or former smokers with preserved pulmonary function who were asymptomatic (CAT score,
Citation impact
- FWCI
- 72.23
- Percentile
- 100%
- References
- 26
Authors
17- PGPrescott G. WoodruffCorresponding
Cornell University, University of California, San Francisco
- RGR. Graham Barr
Cornell University, Columbia University Irving Medical Center
- EREugene R. Bleecker
Cornell University, Wake Forest University
- SAStephanie A. Christenson
Cornell University, University of California, San Francisco
- DCDavid Couper
University of North Carolina at Chapel Hill, Cornell University
Topics & keywords
- Vital capacity
- Spirometry
- Medicine
- COPD
- Pulmonary function testing
- Bronchodilator
- Pulmonary disease
- Bronchodilator Agents
- Good health and well-being
Funding
- FFFoundation for the National Institutes of Health
- AAstraZeneca
- GGlaxoSmithKline
- SSanofi
- IIkaria
- CFChiesi Farmaceutici
- RPRegeneron Pharmaceuticals
- GGrifols
- NINational Institutes of HealthAwards: HHSN268200900013C, HHSN268200900016C, HHSN268200900015C, HHSN268200900018C, HHSN268200900020C, HHSN268200900019C, HHSN268200900014C
- NHNational Heart, Lung, and Blood InstituteAwards: HHSN268200900014C, HHSN268200900018C, HHSN268200900016C, HHSN268200900015C, HHSN268200900020C, HHSN268200900013C, HHSN2682009000019C, HHSN268200900019C